| 产品详情 |
| Edit |   |
|---|
| Product Name | Doramapimod |
|---|
| Description | Purity ~98% (HPLC). Cell-permeable. A potent protein kinase inhibitor with a >330-fold selectivity for p38 MAPK compared with 12 other protein kinases. In contrast to other p38 MAPK inhibitors, doramapimod prevents both the kinetic activity and phosphorylation of p38 MAPK by binding to the ATP pocket as well as to a novel allosteric binding site on p38 MAPK. Solubility: ~50mg/ml (DMSO), ~30mg/ml (EtOH) Molecular Weight: ~527.66 |
|---|
| Size | 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Doramapimod (1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea, BRRB 796) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 167812 |
|---|
| Price | |
|---|
| Order / More Info | Doramapimod from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|